Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Political Reporter Online.
Press releases published on April 3, 2025
B.C. Forests Minister announces new Forestry Support Bureau, promising action to protect jobs and strengthen the sector
GlobeNewswire
·
April 3, 2025
Statement from Scott Lunny, United Steelworkers (USW) Western Canada Director, on new Forestry Support Bureau announced by B.C. Minister of Forests Ravi Parmar: VICTORIA, British Columbia, April 03, 2025 (GLOBE NEWSWIRE) -- At the recent meeting of United …
GOGL – Notice of Annual General Meeting 2025
GlobeNewswire
·
April 3, 2025
Golden Ocean Group Limited (NASDAQ and OSE: GOGL) (“GOGL” or the “Company”) advises that the 2025 Annual General Meeting of the Company will be held on May 8, 2025. The record date for voting at the Annual General Meeting is set to April 7, 2025. A copy of …
Orion Corporation: Organising meeting of the Board of Directors
GlobeNewswire
·
April 3, 2025
ORION CORPORATION STOCK EXCHANGE RELEASE – OTHER INFORMATION DISCLOSED ACCORDING TO THE RULES OF THE EXCHANGE 3 APRIL 2025 at 16.25 EEST Orion Corporation: Organising meeting of the Board of Directors In its organising meeting, the Board …
Orion Oyj:n hallituksen järjestäytymiskokous
GlobeNewswire
·
April 3, 2025
ORION OYJ PÖRSSITIEDOTE – MUUT PÖRSSIN SÄÄNTÖJEN NOJALLA JULKISTETTAVAT TIEDOT 3.4.2025 KLO 16.25 Orion Oyj:n hallituksen järjestäytymiskokous Orion Oyj:n tänään pidetyssä varsinaisessa yhtiökokouksessa valittu hallitus on …
Decisions taken by Orion Corporation’s Annual General Meeting on 3 April 2025
GlobeNewswire
·
April 3, 2025
ORION CORPORATION STOCK EXCHANGE RELEASE – DECISIONS OF GENERAL MEETING 3 APRIL 2025 at 16.20 EEST Decisions taken by Orion Corporation’s Annual General Meeting on 3 April 2025 At the Annual General Meeting of Orion Corporation held today, the …
Orion Oyj:n varsinaisen yhtiökokouksen päätökset 3.4.2025
GlobeNewswire
·
April 3, 2025
ORION OYJ PÖRSSITIEDOTE – YHTIÖKOKOUKSEN PÄÄTÖKSET 3.4.2025 KLO 16.20 Orion Oyj:n varsinaisen yhtiökokouksen päätökset 3.4.2025 Orion Oyj:n tänään pidetty varsinainen yhtiökokous: Vahvisti maksettavaksi osingoksi 1,64 …
Patriot Mobile Fights to Keep Men Out of Women’s Bathrooms and Locker Rooms
GlobeNewswire
·
April 3, 2025
Austin, TX, April 03, 2025 (GLOBE NEWSWIRE) -- Today Patriot Mobile is making a public statement in support of Texas Senate Bill 240 that protects girls and women in private spaces. Texas Senate Bill 240 protects women and girls in bathrooms and locker …
American Rebel Holdings, Inc. (NASDAQ: AREB) Invites Patriotic Investors, Fans, and Beer Enthusiasts to Celebrate Freedom with a New Video Release Highlighting the American Rebel Story
GlobeNewswire
·
April 3, 2025
Watch the American Rebel Story and learn about America’s Next Great Company as told by CEO Andy Ross Nashville, TN, April 03, 2025 (GLOBE NEWSWIRE) -- American Rebel Holdings, Inc. (NASDAQ: AREB), the creator of American Rebel Beer and champion of …
Duke Robotics Provides Update on Progress with Elbit Systems Regarding “Birds of Prey” Stabilized Weapons Drone System
GlobeNewswire
·
April 3, 2025
FT. LAUDERDALE, FL, April 03, 2025 (GLOBE NEWSWIRE) -- Duke Robotics Corp. (OTCQB: DUKR) ("Duke Robotics" or the "Company"), a leader in advanced robotics technology and autonomous drone solutions, today provided an update regarding developments in its …
Press Release: Rilzabrutinib granted orphan drug designation in the US for two rare diseases with no approved medicines
GlobeNewswire
·
April 3, 2025
Rilzabrutinib granted orphan drug designation in the US for two rare diseases with no approved medicines Designation granted for warm autoimmune hemolytic anemia and IgG4-related disease Rilzabrutinib is currently under regulatory review in the US, EU and …
Communiqué de presse : Le rilzabrutinib obtient la désignation de médicament orphelin aux États-Unis pour le traitement de deux maladies rares contre lesquelles il n’existe aucun médicament approuvé
GlobeNewswire
·
April 3, 2025
Le rilzabrutinib obtient la désignation de médicament orphelin aux États-Unis pour le traitement de deux maladies rares contre lesquelles il n’existe aucun médicament approuvé Désignation accordée pour l’anémie hémolytique à anticorps chauds et la maladie …